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2Abstract
The mRNA nuclear export receptor Mex67/Mtr2 is recruited to mRNAs through RNA-
binding adaptors including components of the THO/TREX complex that couple
transcription to mRNA export. Here we show that the ubiquitin-associated (UBA)
domain of Mex67 is not only required for proper nuclear export of mRNA but also
contributes to recruitment of Mex67 to transcribing genes. Our results reveal that the
UBA domain of Mex67 directly interacts with polyubiquitin chains and with Hpr1, a
component of the THO/TREX complex, which is regulated by ubiquitylation in a
transcription-dependent manner. This interaction transiently protects Hpr1 from
ubiquitin/proteasome-mediated degradation and thereby coordinates recruitment of the
mRNA export machinery with transcription and early mRNP assembly.
3Introduction
Concomitantly to their transcription, nascent transcripts are loaded with mRNA binding
proteins implicated in the processing and packaging of mRNA into stable and export
competent mRNPs. The production of mature mRNPs involves 5’ capping, splicing, 3’end
cleavage/polyadenylation. All these co-transcriptional but biochemically distinct reactions are
tightly coupled and coordinated by the RNA polymerase II C-terminal domain (CTD), which
acts as a recruitment platform for the different processing machineries (1-5).
Fully mature and correctly packaged yeast mRNPs are released from the transcription
site and transported into the cytoplasm by the heterodimeric export receptor Mex67/Mtr2 (or
TAP/p15 in metazoan), which promotes their translocation through the nuclear pore
complexes (NPC) via direct interactions with FG-nucleoporins (6). Mtr2 promotes the
interaction of Mex67 with the NPC (7). The adaptor protein Yra1/REF contributes to mRNA
export by facilitating the binding of Mex67 to the mRNP (8, 9). Yra1/REF and its partner
Sub2 (UAP56 in metazoan) become associated with nascent transcripts during transcription
elongation (10, 11). Yra1 and Sub2 co-purify with THO, a tetrameric complex associated with
the transcription machinery, to form the TREX complex proposed to link mRNA transcription
and export (12). Constituants of THO include Hpr1, Tho2, Mft1 and Thp2 (12, 13), and
evidence supports the notion that early recruitment of Sub2 is promoted through its direct
interaction with Hpr1. Sub2 may then in turn facilitate the loading of Yra1 to mRNA (11, 12,
14, 15).
Loss of any of the four THO components impairs transcription elongation, genome
stability and mRNA export (12, 13). The current view is that THO primarily contributes to
efficient mRNP assembly by promoting correct loading of mRNA binding proteins. In THO
mutants, the production of improperly packaged mRNP complexes results in the formation of
DNA-RNA hybrids (R-loops), which interfere with RNA polymerase II processivity and
4transcription elongation and consequently increase transcription-dependent recombination
events (16, 17). Furthermore, the absence of THO components induces retention and
eventually degradation of malformed transcripts, i.e. heat-shock HSP104 mRNAs, at or close
to the transcription site by nuclear surveillance mechanisms (18).
Previous studies have indicated that the ubiquitin pathway is involved in regulation of
nuclear transport of both poly(A)+RNA and proteins (19). In particular, Tom1 and Rsp5, two
ubiquitin ligases from the HECT family have been shown to play a role in nuclear export of
poly(A)+RNA in S. cerevisiae (20-23). We recently reported that Hpr1, a component of the
THO complex is poly-ubiquitylated both in vitro and in vivo by Rsp5 prior to its degradation
by the 26S proteasome. Hpr1 turnover, which is more active at 37°C, appeared linked to on-
going RNA-polymerase II–dependent transcription whereas the other members of the THO
complex such as Mft1 or Thp2 were not affected in similar conditions (24). Hpr1 thus
represents a key factor whose stability controls the integrity and activity of the whole THO
complex. Paradoxically, HPR1 deletion, but also Hpr1 stabilization by inactivation of Rsp5
correlated with a poly(A)+ RNA nuclear export defect, suggesting that tight control of both
expression and active ubiquitin-dependent turnover of Hpr1 is required for proper transport
function.
The large array of cellular processes involving ubiquitin modification is likely
mediated through recognition of ubiquitin moieties by effectors containing ubiquitin-binding
domains. Several families of ubiquitin-interacting motifs have been recently identified
including UBA (Ubiquitin Associated), the most frequent ubiquitin-binding motif, UIM
(Ubiquitin interacting motif), CUE (coupling of ubiquitin conjugation to endoplasmic
reticulum), NZF (Npl4 Zn finger), UEV (ubiquitin E2 enzyme variant) (reviewed in (25).
Structural and molecular features of UBA-ubiquitin interactions and ubiquitin linkage
selectivity have been analyzed in a restricted number of UBA-containing proteins,
5exemplified by yeast Rad23 or its human ortholog hHR23A, leading to the general
assumption that UBA domains preferentially interact with Lys48-linked poly-ubiquitylated
proteins (26-32). In contrast to this current view, a recent study on 30 distinct UBA motifs
revealed that, in vitro, a UBA motif may or not be selective for the ubiquitin linkage but may
also display no measurable affinity for ubiquitin (33). In addition, the idea emerges that the
intra-molecular environment of a UBA domain may influence the specificity of the UBA
domain (33), but ubiquitin-binding domains described to date have not been reported to
display any particular specificity for a ubiquitylated protein. Interestingly the yeast mRNA
export receptor Mex67 as well as its metazoan counterpart TAP harbor a UBA domain in their
C-terminus that participates in the interaction with FG-nucleoporins at nuclear pores while
their N-terminal domain binds mRNP via RNA-binding adaptors (8, 9, 34-37). The UBA
domain of Mex67 consists of the characteristic triple helix bundle plus an additional fourth
helix. Mex67 is so far the only nuclear transport factor containing an ubiquitin-associating
motif but its role in connecting mRNA nuclear export to regulation by ubiquitin modification
remains to be determined.
Here we show that Mex67 is recruited to transcribing genes and that its UBA domain
contributes to its  recruitment. Lack of  recruitment correlates with a defect in mRNA export.
Our data show that the UBA domain of Mex67 not only recognizes ubiquitin and
polyubiquitylated proteins but also physically interacts with Hpr1. In addition, an excess of
UBA-Mex67 or the absence of UBA (Mex67-∆UBA), respectively, induces a decrease or an
increase in the rate of degradation of Hpr1, consistent with a role for the UBA-Mex67 domain
in transient protection of ubiquitylated Hpr1 from degradation by the 26S proteasome. The
Mex67-Hpr1 interaction may contribute to the appropriate coordination of the different steps
of mRNP biogenesis
6Results and Discussion
To precisely characterize the function of the UBA domain of Mex67 (UBA-Mex67) in mRNA
nuclear export, the subcellular distribution of mRNA was analyzed upon deletion or
overexpression of the UBA-Mex67 domain. Strains were constructed that lacked the
chromosomal MEX67 gene and expressed HA-tagged wild-type Mex67 (Mex67-3HA) or
Mex67∆UBA (mex67∆UBA-3HA) from a plasmid. Western blotting with anti-HA antibodies
confirmed that the wild-type protein (encoding amino acids 1-599) and the mutant protein
(encoding amino acids 1-542) were expressed to comparable levels (not shown). In agreement
with previous results reported by (7), deletion of the UBA-Mex67 domain rendered cells
thermosensitive for growth at 37°C (not shown). It should be noted that the Mex67∆UBA
protein used in this former study lacked the C-terminal 75 amino acids whereas
Mex67∆UBA-3HA only lacks the last 57 amino acids strictly corresponding to the UBA
domain. Consistent with its growth phenotype, the mex67∆UBA-3HA strain displayed a weak
mRNA export defect at 23°C (8% of the cells with nuclear accumulation of poly(A)+RNA)
whereas poly(A)+RNA accumulated in the nucleus of 74% of the cells after a 1h shift to the
restrictive temperature. In contrast, only 1% of the Mex67-3HA cells presented nuclear
accumulation of poly(A)+RNA under the same experimental conditions (Figure 1A).
Similarly, yeast cells over-expressing the Lex-UBA chimeric protein clearly accumulated
poly(A)+RNA in their nucleus after a 2h-shift to 37°C compared to 23°C or to control cells
(Figure 1C). GAL1 mRNA, whose transcription was induced for 90 min in galactose at 23°C
mainly accumulated within a nuclear dot at or close to the site of transcription and was poorly
detected in the cytoplasm of mex67∆UBA-3HA cells whereas this mRNA was distributed
throughout Mex67-3HA cells with a detectable but much weaker dot staining, indicating a
role for the UBA-Mex67 domain in the release and export of this specific transcript (Figure
1B). These results indicate that the UBA domain is required for Mex67 to ensure proper
7nuclear export function. The more pronounced effect of UBA deletion both on cell growth
and on nuclear export at 37°C and the capacity of Mex67∆UBA to bind nucleoporins in vitro
(7) suggest that the UBA domain may play a role distinct from its nuclear pore complex
targeting function.
Mex67/Mtr2 is recruited to mature mRNPs through RNA-binding adaptors that
interact with its N-terminal domain. To determine whether the UBA-Mex67 domain may
function in an earlier more upstream event of mRNA biogenesis, the ability of Mex67 to be
recruited to actively transcribed genes was analyzed by chromatin immunoprecipitation
(ChIP) of the galactose inducible GAL10 gene (Figure 2A) and the constitutively expressed
PMA1 gene in cells grown respectively in galactose and glucose (Figure 2B). Our results
show that Mex67 becomes associated with the PMA1 gene and with GAL10 when cells are
grown in galactose indicating that recruitment of Mex67 is transcription-dependent (Figure 2).
Mex67 was enriched in the middle of both PMA1 and GAL10 genes showing an association
profile similar to that observed earlier for the THO complex component Hpr1 and the mRNA
adaptor Yra1 (Figure 2A and B; (11)). Interestingly, absence of the UBA domain resulted in
the clear decrease of co-transcriptional recruitment of Mex67 all along GAL10 and PMA1
genes (Figure 2 A and B). However neither CTD nor Yra1 recruitment was significantly
affected in the mutant, indicating that the reduced recruitment of Mex67-∆UBA was not a
consequence of a transcriptional defect and that the co-transcriptional recruitment of Mex67-
3HA was mainly due to its UBA domain (Figure 2A and B). Despite a normal recruitment of
both CTD and Yra1 in mex67∆UBA-3HA cells, we observed a decrease of Hpr1 on GAL10
gene in these cells, again suggesting that UBA-Mex67 could interfere with the function of
some factors involved in the coupling between transcription and mRNA export (Figure 2B
and see below).
8To dissect the mechanisms responsible for the roles of UBA-Mex67, partners of this
domain were searched using a two-hybrid screen. This strategy allowed the identification of a
203 amino acid C-terminal fragment of Hpr1 (aa 548-752) that interacted with UBA-Mex67,
as well as with full-length Mex67. No interaction was observed with Mex67 lacking its UBA
domain (Figure 3A). The specificity of the interaction between Hpr1 and Mex67 was
confirmed using UBA-Rad23 as well as an Hpr1 molecule deleted of its C-terminal fragment
(Hpr1(1−547)). Interestingly, no significant interaction was measured between UBA-Mex67
and Mft1 or Thp2, suggesting that the interaction between Mex67 and Hpr1 does not involve
the other members of the THO complex (Figure 3A). In agreement with the 2-hybrid results,
recombinant purified His-tagged UBA-Mex67 could interact in vitro with GST-Hpr1. This
interaction occurred through the C-terminal fragment of Hpr1 (GST-Hpr1 (548-752))
corresponding to the 2-hybrid fragment, whereas a smaller C-terminal fragment (Hpr1 (652-
752)) was not sufficient to significantly bind UBA-Mex67 in vitro (Figure 3B). Finally, co-
immunoprecipitation was equally observed between Hpr1-HA and Mex67, and Thp2-HA and
Mex67, indicating that Mex67 can interact with Hpr1 in the context of the THO complex in
intact cells when expressed at physiological levels (Figure 3C). However, no co-
immunoprecipitation between Mex67 and Thp2-HA could be observed in absence of Hpr1
(Figure 3C) thus demonstrating that this interaction is also mediated by Hpr1 in vivo.
Together, these results clearly show that UBA-Mex67 promotes binding of Mex67 to Hpr1
whereas an unrelated UBA domain cannot provide this function.
Based on a few well-studied examples such as UBA-Rad23, UBA folds are believed to
interact with and either expose or protect poly-ubiquitylated substrates to/from the 26S
proteasome (38-40). However, a recent study on 30 distinct UBA domains revealed that about
30% of UBA domains do not bind mono- or polyubiquitin chains (33). The ability of UBA-
Mex67 to interact with ubiquitin moieties was therefore carefully analyzed both in vivo and in
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mRNA export receptor was able to bind poly-ubiquitylated cellular proteins accumulated
upon treatment with the proteasome inhibitor MG132 (Figure 4A). In vitro titration
experiments indicate that GST-Mex67/Mtr2 clearly interacts with ubiquitin with a higher
affinity for tetra-ubiquitin (Kd=5.9+/-0.7 µM) than for monoubiquitin (Kd=22.7+/-4.2 µM),
values comparable with those reported for other proteins harboring a UBA domain (33, 39).
Importantly, deletion of the UBA domain abolished the ability of Mex67 to bind ubiquitin
both in vivo and in vitro (Kd>400 µM; Figure 4A and 4B). These results therefore
demonstrate that Mex67 binds poly-ubiquitylated cellular proteins through its UBA domain.
We recently reported that Rsp5, a WW domain-containing ubiquitin ligase involved in
the control of mRNA export (22, 24) poly-ubiquitylates Hpr1 prior to its degradation by the
proteasome in a temperature and transcription-dependent fashion. The lysine-rich C-terminal
domain of Hpr1 is not only required for proper ubiquitylation and degradation of Hpr1 (24)
but also for interaction with UBA-Mex67 (Figure 3A and B), suggesting that ubiquitylation of
Hpr1 may influence its binding to UBA-Mex67, which might in turn affect Hpr1 degradation.
To examine the potential effect of the UBA-Mex67 domain on Hpr1 turnover, Hpr1 levels
were analyzed when the UBA domain was either absent or present in excess. The data show
that loss of UBA-Mex67 resulted in faster degradation of Hpr1 after a shift to 37°C, whereas
overexpression of Lex-UBA-Mex67 was able to protect Hpr1 from degradation at 37°C when
compared to overexpression of the Lex-UBA-Rad23 fusion protein (Figure 4C). Interfering
with the interaction between Hpr1 and Mex67 thus clearly affects the degradation of Hpr1. To
distinguish whether the interaction of Hpr1 with UBA-Mex67 prevents Hpr1 degradation by
inhibiting Hpr1 ubiquitylation or rather by protecting the polyubiquitin chain from the
proteasome, polyubiquitin-conjugated species of Hpr1 were analyzed upon overexpression of
UBA-Mex67 or UBA-Rad23. For this purpose, His6-tagged ubiquitin and UBA domains
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were overexpressed in cim3.1 temperature-sensitive mutants, impaired in proteasomal activity
and grown at the restrictive temperature (24). Affinity purification followed by Western blot
analysis showed that polyubiquitylated species of Hpr1 accumulated upon over-expression of
UBA-Mex67 compared to UBA-Rad23 (Figure 4D). In agreement with these results, we
found that, in vitro, the affinity of UBA-Mex67 for ubiquitin was strongly increased upon
binding to Hpr1 (Hobeika et al., unpublished observations). The specificity of the interaction
between UBA-Mex67 and Hpr1 thus allows UBA-Mex67 to interfere with the
ubiquitin/proteasome-mediated degradation of Hpr1 by transiently protecting ubiquitylated
Hpr1 from the 26S proteasome.
To determine whether the interaction between UBA-Mex67 and ubiquitylated Hpr1
not only affects Hpr1 turnover but also contributes to the co-transcriptional recruitment of
Mex67 and mRNA export, these functions were analyzed in a mutant affected in Hpr1
ubiquitylation. The interaction between Rsp5 E3 ligase and Hpr1 most likely involves the
recognition of the LPxY motif of Hpr1 (amino-acids 335-338, Figure 5A) by the second and
third WW repeats of Rsp5 (22, 24). Indeed mutation of tyrosine 338 to alanine (hpr1-Y338A)
slowed down Hpr1 turnover at 37°C confirming that ubiquitin-dependent degradation of Hpr1
is affected by a mutation in the Rsp5-binding motif LPxY (Figure 5A). This partial block in
Hpr1 ubiquitylation also resulted in a defect of GAL1 mRNA nuclear export illustrated by a
clear and reproducible accumulation of GAL1 mRNA within a marked nuclear dot and a lack
of cytoplasmic staining after a 30 minute shift to galactose at 30°C in a majority of hpr1-
Y338A cells compared to the wt cells (Figure 5B). However, GAL1 transcripts were detected
in the cytoplasm after longer time points indicating that this partial defect most likely results
from a delayed release from the transcription site rather than an export defect per se.
Accordingly, this ubiquitylation defect led to a 40% decrease of the co-transcriptional
recruitment of Mex67 to the GAL10 gene at 25°C. This effect did not result from a decreased
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transcription of the gene nor a defect in hpr1-Y338A recruitment or THO complex formation
and recruitment, as measured by the association of CTD, Hpr1 and Thp2 respectively (Figure
5C). Notably, the hpr1-Y338A mutation resulted in a slight increase of CTD and Hpr1
recruitment on GAL10 whereas recruitment of Thp2 remained unchanged suggesting that
Hpr1 ubiquitylation could influence the THO complex integrity to some extent. Together
these data are consistent with the RNA-independent early binding of Mex67 (41) and further
support the view that ubiquitylation of Hpr1 facilitates co-transcriptional recruitment of
Mex67 and mRNA export by mediating an interaction with the UBA domain of Mex67.
Hpr1 is a key component of the THO complex whose stability is likely to control the
integrity and activity of the whole THO complex (12, 24). Because ubiquitylation of Hpr1
depends on active transcription, the UBA-Mex67-mediated recruitment of Mex67 and
protection of Hpr1 are likely to occur during transcription itself and may contribute to
increasing the local concentration of Mex67 in the vicinity of transcribed genes, and to
coordinating THO complex metabolism and mRNA export. In other words, ubiquitin-
mediated degradation does not appear to be the "raison d'être" of this modification but a
consequence of the accomplished assembly/recruitment function. The mechanisms described
here represent the first example of the role of poly-ubiquitylation in the coordination between
transcription and nuclear export through the tight control of the transport machinery assembly,
disassembly and degradation. The involvement of at least another ubiquitin ligase Tom1 (20,
21), in the regulation of mRNA export, leads us to suspect that such a mechanism is not likely
to be unique and could be used by eukaryotic cells to organize and control the chronology of
concerted molecular events.
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Experimental Procedures
Plasmids and Cloning. See Supplementary informations
FISH experiments. DF5 strain transformed with p426GAL1 plasmid encoding the fusion
protein Lex-UBA-Mex67 or the empty vector were grown in YEP / 2% raffinose / 0.02%
glucose medium at 23°C. The expression of Lex-UBA protein was induced by addition of 2%
galactose over-night at 23°C. At OD600 = 0.8 cells were shifted to 37°C for 2 h. These cells
were then analyzed by in situ hybridization (FISH) using Cy3 labeled oligo dT(50) performed
as previously described (22, 43). Poly(A)+ mRNA in situ hybridization in Mex67-3HA and
mex67-∆UBA-3HA strains was performed using Cy3 labeled oligo dT(50) on cells grown at
23°C or heated for 1 hour at 37°C. Results were quantified by counting, in a blind experiment,
the number of cells accumulating poly(A)+ mRNA in the nucleus within a total of 100 cells
per each condition. GAL1 mRNA in situ hybridization in Mex67-3HA and mex67-∆UBA-
3HA or in Hpr1 wt and hpr1Y338A strains was performed on cells treated for 90 min with
galactose at 25°C or 30 min with galactose at 30°C, respectively, using six Cy3-internally-
labelled 50mer oligonucleotide probes.
Chromatin immunoprecipitation (ChIP) analysis. See Supplementary information.
Purification of 6His-tagged Ubiquitin-Hpr1 conjugates. cim3.1 ts cells expressing Hpr1-
HA were transformed with a plasmid encoding 6His-ubiquitin under the CUP1 promoter (46)
and a plasmid encoding Lex-UBA-Mex67 or Lex-UBA-Rad23 from the ADH promoter.
Cells were grown on selective media supplemented with 0.1mM of CuSO4 and shifted to
37°C for 4 h. Purification was performed essentially as described previously (24) from 50
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OD600 of cells (2.3 mg of total proteins) and modified Hpr1 was detected using anti-HA
antibody (Babco).
Co-Immunoprecipitation experiments. Yeast cells expressing Hpr1-HA or Thp2-HA were
grown up to an OD600= 1.2. Cells were harvested and lysed at 4°C with glass beads in ice-cold
IP buffer. The lysate was centrifuged for 30 min at 13000g. The supernatant was incubated
with protein G–Sepharose beads (Amersham) and anti-Mex67 or preimmune antibodies for 2h
at 4 °C. Beads were then washed with IP buffer and bound proteins were eluted by heating
samples at 95°C for 5 min in Laemmli sample buffer before Western-blot analysis using anti-
Mex67 (24) or anti-HA antibodies (Babco).
Fluorescence titration experiments: Binding of Mex67, Mex67∆UBA and Rad23 to
ubiquitin and tetra ubiquitin was monitored by steady-state fluorescence spectroscopy as
previously described (27). Fluorescence titrations were performed in 20 mM Tris-HCl (pH:
7.2), 150 mM NaCl, 2 mM EDTA, 1% glycerol, at 25 °C. Fluorescently labelled ubiquitin and
tetra-ubiquitin were prepared and purified as described (27). A fixed concentration of
fluorescently labelled ubiquitin or tetra-ubiquitin (1 µM) was titrated with increasing
concentrations of Mex67, Mex67∆UBA, Rad23 and Mtr2 proteins. Fluorescence was
measured at 460 nm upon excitation at 340 nm. Upon binding to either Rad23 or Mex67, the
fluorescence of mono or tetra-ubiquitin increased by a factor of 2 -3. The titration curves were
fitted according to a quadratic equation using Grafit Software (Erithacus Software Ltd) (47).
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Figure legends
Figure 1. The UBA domain of Mex67 contributes to its mRNA export activity (A)
Subcellular localization of poly(A)+ RNA was analyzed by FISH using oligodT Cy3 as probe
in Mex67-3HA or in mex67∆UBA-3HA shuffle strains grown over-night at 23°C and then
shifted to 37°C for 1h. (B) GAL1 mRNA was analyzed by FISH using a specific probe in
Mex67-3HA or mex67∆UBA-3HA shuffle strains after a 30 min induction in galactose at
23°C. (C) Cells expressing Lex or Lex-UBA Mex67 under the control of a galactose inducible
promoter were grown over-night in galactose containing medium at 23°C and then shifted to
37°C for 2h prior to FISH analysis using oligodT Cy3 as probe.
Figure 2. The UBA domain of Mex67 contributes to its co-transcriptional recruitment. (A)
ChIP experiments on GAL10 gene were performed with extracts prepared from Mex67-3HA
or mex67∆UBA-3HA strains shifted to galactose for 2h using indicated antibodies. (B) ChIP
experiments on PMA1 gene were performed with extracts prepared from Mex67-3HA or
mex67∆UBA-3HA strains using antibodies against HA or RNA polymerase II C-terminal
domain (CTD). Each immunoprecipitation was repeated at least from three different extracts.
Error bars correspond to standard deviations.
Figure 3. The UBA domain of Mex67 interacts with Hpr1. (A) Two-hybrid analysis of the
Lex-Mex67 baits versus Gal4-Hpr1 derived preys. (B) Purified recombinant UBA-Mex67 and
GST-Hpr1 fusion proteins were mixed (input) and complexes were analyzed after purification
on glutathione-sepharose beads (bound). (C) In vivo Mex67/THO complex interaction was
analyzed by co-immunoprecipitating HA-tagged Hpr1 with anti-Mex67 antibodies or
20
alternatively HA-tagged Thp2 with anti-Mex67 antibodies in Thp2-HA (HPR1) or
∆hpr1/Thp2-HA (∆hpr1) strains. Pre-immune serum (IP mock) was used as negative control.
Figure 4. The UBA domain of Mex67 interacts with polyubiquitin chains and prevents
proteasome-mediated degradation of Hpr1. (A) Pull-down assays using the indicated GST
fusion recombinant proteins and extracts from ∆erg6 cells +/- MG132. (B) Dissociation
constants of Mex67-derived GST fusion proteins and Rad23 for mono- and tetra-ubiquitin.
The association with ubiquitin was measured in vitro by monitoring the fluorescence
enhancement of fluorescently-labeled ubiquitin. (C) The stability of Hpr1-HA was analyzed
in cells (YFS 1748) transformed with a pLex10-UBA-Mex67 or a pLex10-UBA-Rad23
plasmid and collected before (0) or after a shift at 37°C for 15 min in the absence (-CX) or the
presence (+CX) of cycloheximide (left panel) or alternatively in Mex67-3HA or in
mex67∆UBA-3HA shuffle strains shifted to 37°C in the presence of cycloheximide for
different incubation times (right panel). (D) Ni-Purified 6His-ubiquitin conjugated forms of
Hpr1-HA from cim3.1 cells transformed with pYEp96-6His-Ub and a p426ADH-Lex-UBA-
Mex67 or a p426ADH-Lex-UBA-Rad23 plasmid and shifted to 37°C during 4 h. The purified
material was examined by Western blotting with an anti-HA antibody.
Figure 5. Ubiquitylation of Hpr1 is required for proper mRNA export and co-transcriptional
recruitment of Mex67. (A) Mutation Y338A within the Rsp5-binding site of Hpr1 slowed-
down the turnover of Hpr1 (B) GAL1 mRNA localization was analyzed by FISH using a
specific probe in Hpr1wt or hpr1Y338A mutant strains after a 30 min induction in 2%
galactose at 30°C. (C) The association of Mex67 with the 5’, middle, 3’ and 3’UTR regions of
the GAL10 gene was analyzed by ChIP using anti-Mex67, anti-CTD, anti-Hpr1 or anti-HA
antibodies and extracts from Hpr1wt/Thp2-HA or hpr1Y338A/Thp2-HA cells induced with
21
2% galactose for 1h at 25°C. Values correspond to the mean of three independent
experiments.
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Supplementary informations
Plasmids and Cloning. The DNA fragment encoding the 56 amino acid (543-599) UBA
domain of Mex67 and the 56 amino acid (342-398) UBA domain of Rad23 were amplified by
PCR using genomic DNA as a template and cloned as BamHI-SalI fragments into pLex10
(Invitrogen), and then subcloned in the BamHI-SalI sites of PET28a (Novagen). DNA
encoding Lex-UBA-Mex67 or Lex-UBA-Rad23 fusion proteins expressed under the control
of a constitutive or a galactose inducible promoter was obtained by digestion of pLex10-
UBA-Mex67 or pLex10-UBA-Rad23 and subcloned into HindIII-SalI sites of p426 ADH
(2µm, URA3) or p426 GAL1 respectively (42). Full-length MEX67 was subcloned as an
EcoRI fragment from pGEX4T-1-MEX67 (11) into pLex10 vector, in frame with the DNA
binding domain of LexA. A KpnI-BamHI DNA fragment encoding amino acids 513-542 of
Mex67 was amplified by PCR and cloned into the same restriction sites of pLex10-MEX67
(1-513) to generate the pLex10-mex67∆UBA (1-542) construct. DNA encoding GST-
Mex67∆UBA was obtained by digestion of pLex10-mex67∆UBA and subcloned into EcoRI-
SalI sites of pGEX4T-1. For the Hpr1∆C-ter (1-547) construct, two DNA fragments encoding
amino acids 1-373 (BamHI-EcoRV) and 373-547 (EcoRV-SalI) of Hpr1 were obtained by
digestion of the pGEX4T-1-Hpr1 vector and by PCR respectively. Both fragments were
cloned into BamHI-SalI sites of pADGAL4/2.1 vector (Stratagene), in frame with the GAL4
activator domain. A EcoRI DNA fragment encoding amino acids 548-752 or 652-752 of Hpr1
was amplified by PCR and cloned into the same restriction site of pGEX-4T1. To generate
pRS314-MEX67-3-HA and pRS314-mex67-∆UBA-3-HA, a EcoNI-NheI DNA fragment
encoding amino acids 494-599 or 494-542 respectively followed by three HA tags was
subcloned into the same restriction sites in the pRS314-mex∆C1 plasmid (7). These plasmids
were transformed into the MEX67 shuffle strain (mex67::HIS3, pURA3-MEX67, (7)) prior to
selection on 5-FOA plates. Expression levels of Mex67-3HA and Mex67-∆UBA-3HA in the
shuffle strains analyzed by Western blotting with anti-HA antibodies were found similar.
Plasmid YEplac181 (2µm, LEU2) containing the coding sequence of Hpr1 +/- 500 bp was
previously described (11). Site directed Hpr1 PY domain mutants were constructed by
replacing tyrosine 338 by alanine using PCR and confirmed by DNA sequencing. The
plasmids HPR1-wt and hpr1-Y338A were introduced into the ∆hpr1 strain (11) to generate
Hpr1-wt and hpr1-Y338A strains. Expression levels of wild type and mutant Hpr1 were
analyzed by Western blotting with anti-Hpr1 antibodies and found to be similar.
Chromatin immunoprecipitation (ChIP) analysis. ChIPs were performed as described
previously (11, 44) except that cells were cross-linked by incubation with 1.2% formaldehyde
for only 10 min. The role of the UBA domain in Mex67 recruitment to GAL10 was addressed
by comparing extracts from the Mex67-3HA and mex67∆UBA-3HA shuffled strains. The
cells were grown in YEP 2% raffinose to OD600=1, and induced by the addition of one volume
YEP 4% galactose for 2h at 25°C prior to cross-linking. The role of the Hpr1-PY domain in
Mex67 recruitment to the GAL10  gene was analyzed by comparing extracts from
Hpr1wt/Thp2-HA and hpr1Y338A/Thp2-HA strains pre-grown in Leu- 2% raffinose at 25°C
to OD600=1, induced by the addition of one volume Leu- 4% galactose, for 1h at 25°C prior to
cross-linking. Sonicated extracts from both experiments were immunoprecipitated with
antibodies against HA (16B12 from Covance), RNA polymerase II C-terminal domain (CTD ;
8W16G from Covance), Mex67 and Hpr1 as indicated. Each immunoprecipitation was
repeated at least from three different extracts. Immunoprecipitated DNA was analysed by
quantitative PCR using the following GAL10 primer pairs: 
GAL10 5’ (OFS1061 5 ’CACTGTGGTAGAGCTAATTGAGAATGG3’,  OFS1062
5’AAGACCTCTAACCTGGCTACAGAATC3’),
GAL10  midd le  (OFS1063  5’CCAGTTAAGGGGTGTCGAGGC3’, OFS1064
5’AAATTGGCAAACGTGGCTTGAAATC3’),
GAL10 3’ (OFS1065 5 ’ C A A G A C A A G G T T T T G C A A T T G A G C C 3 ’,  OFS1066
5’CAATCTTGGACCCGTAAGTTTCACC3’)
GAL10 3’UTR (OFS1067 5’TGTAGGGACCGAATTGTTTACAAGTTC3’, OFS1068
5’GTTGCTACCGTCCATATCTTTCCATAG3’).
To calculate the fold increase in signal in the different GAL10 regions, the absolute values
obtained by quantitative PCR were normalized to the values obtained with the non-transcribed
intergenic region.
The role of the UBA domain in Mex67 recruitment to PMA1 was addressed by comparing
extracts from the Mex67-3HA and mex67∆UBA-3HA shuffled strains. Cells were grown at
25°C in YEP 2% glucose to OD600=1 prior to cross-linking. Sonicated extracts were
immunoprecipitated with antibodies against HA or RNA polII CTD. Each
immunoprecipitation was repeated at least from at least three different extracts.
Immunoprecipitated DNA was analysed by quantitative PCR as described above using the
following PMA1 primer pairs: PMA1 5’ (OFS705 5’TCAGCTCATCAGCCAACTCAAG3’,
O F S 7 0 6  5’CGTCGACACCGTGATTAGATTG3’) ,  P M A 1  m i d d l e  ( O F S 7 4 1
5’TTGCCAGCTGTCGTTACCAC3’, OFS742 5’TCGACACCAGCCAAGGATTC3’), PMA1 3’
( O F S 7 0 8  5’TACTGTCGTCCGTGTCTGGATCT3’,  O F S 7 0 9
5’CCTTCATTGGCTTACCGTTCA3’).
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